BRYTIVA Trademark

Trademark Overview

On Friday, July 17, 2020, a trademark application was filed for BRYTIVA with the United States Patent and Trademark Office. The USPTO has given the BRYTIVA trademark a serial number of 90059030. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 4, 2024. This trademark is owned by Cortexyme, Inc.. The BRYTIVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, medicinal and biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, diabetes, cardiovascular diseases, cancers, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders

General Information

Serial Number90059030
Word MarkBRYTIVA
Filing DateFriday, July 17, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2020

Trademark Statements

Goods and ServicesPharmaceutical, medicinal and biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, diabetes, cardiovascular diseases, cancers, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLIGHTHOUSE PHARMACEUTICALS, INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN FRANCISCO, CA 94131
Party NameQUINCE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080
Party NameCortexyme, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameCortexyme, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, July 21, 2020NEW APPLICATION ENTERED
Thursday, August 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 30, 2020ASSIGNED TO EXAMINER
Tuesday, November 3, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 3, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, November 3, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 3, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, November 3, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 18, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 8, 2020PUBLISHED FOR OPPOSITION
Tuesday, December 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 19, 2021ASSIGNED TO EXAMINER
Tuesday, February 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 21, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, July 21, 2021SOU EXTENSION 1 FILED
Wednesday, July 21, 2021SOU EXTENSION 1 GRANTED
Friday, July 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 17, 2022SOU TEAS EXTENSION RECEIVED
Monday, January 17, 2022SOU EXTENSION 2 FILED
Monday, January 17, 2022SOU EXTENSION 2 GRANTED
Thursday, January 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 27, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, July 27, 2022SOU EXTENSION 3 FILED
Wednesday, July 27, 2022SOU EXTENSION 3 GRANTED
Friday, July 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 1, 2023SOU EXTENSION 4 FILED
Wednesday, February 1, 2023SOU EXTENSION 4 GRANTED
Wednesday, February 1, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 1, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 1, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 1, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, February 1, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 1, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 15, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, July 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 14, 2023SOU EXTENSION 5 FILED
Friday, July 21, 2023SOU EXTENSION 5 GRANTED
Saturday, July 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, March 4, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, July 21, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

brytiva diseases disorders disease periodontal cancers cardiovascular blood pain obesity cognitive